 LexaGene Holdings, Inc. said it has successfully utilized its MiQLab System to detect the presence of multiple strains of pathogenic bacteria in polymicrobial samples that vary in their antimicrobial resistance AMR. The company said these samples were missed by traditional Culture and Sensitivity Testing CST, and the time-to-results were orders-of-magnitude faster for the MiQLab. 